当前位置:
X-MOL 学术
›
Am. J. Respir. Crit. Care Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
C-reactive Protein-based Screening of People with Tuberculosis Symptoms: A Diagnostic Accuracy Study.
American Journal of Respiratory and Critical Care Medicine ( IF 19.3 ) Pub Date : 2024-12-06 , DOI: 10.1164/rccm.202405-1000oc Brigitta Derendinger,Tessa K Mochizuki,Danaida Marcelo,Deepa Shankar,Wilson Mangeni,Hanh Nguyen,Seda Yerlikaya,William Worodria,Charles Yu,Nhung Viet Nguyen,Devasahayam Jesudas Christopher,Grant Theron,Patrick Pj Phillips,Payam Nahid,Claudia M Denkinger,Adithya Cattamanchi,Christina Yoon
American Journal of Respiratory and Critical Care Medicine ( IF 19.3 ) Pub Date : 2024-12-06 , DOI: 10.1164/rccm.202405-1000oc Brigitta Derendinger,Tessa K Mochizuki,Danaida Marcelo,Deepa Shankar,Wilson Mangeni,Hanh Nguyen,Seda Yerlikaya,William Worodria,Charles Yu,Nhung Viet Nguyen,Devasahayam Jesudas Christopher,Grant Theron,Patrick Pj Phillips,Payam Nahid,Claudia M Denkinger,Adithya Cattamanchi,Christina Yoon
Rationale: C-reactive protein (CRP)-based tuberculosis (TB) screening is recommended for people with HIV (PWH). However, its performance among people without HIV and in diverse settings is unknown. Objectives: In a multi-country study, we aimed to determine whether CRP meets the minimum accuracy targets (sensitivity ≥90%, specificity ≥70%) for an effective TB screening test. Methods/Measurements: Consecutive outpatient adults with cough ≥2 weeks from five TB endemic countries in Africa and Asia had baseline blood collected for point-of-care CRP testing and HIV and diabetes screening. Sputum samples were collected for Xpert MTB/RIF Ultra (Xpert) testing and culture. CRP sensitivity and specificity (5 mg/L cut-point) was determined in reference to sputum test results and compared by country, sex, and HIV and diabetes status. Variables affecting CRP performance were identified using a multivariate receiver operating characteristic (ROC) regression model. Results: Among 2904 participants, of whom 613 (21%) had microbiologically-confirmed TB, CRP sensitivity was 84% (95% CI: 81-87%) and specificity was 61% (95% CI: 59-63%). CRP accuracy varied geographically, with higher sensitivity in African countries (≥91%) than Asian countries (64-82%). Sensitivity was higher among men than women (87% vs. 79%, difference +8%, 95% CI: 1-15%) and specificity was higher among people without HIV than PWH (64% vs. 45%, difference +19%, 95% CI: 13-25%). ROC regression identified country and measures of TB disease severity as predictors of CRP performance. Conclusions: Overall, CRP did not achieve the minimum accuracy targets and its performance varied by setting and in some sub-groups, likely reflecting population differences in mycobacterial load.
中文翻译:
基于 C 反应蛋白的结核病症状筛查:一项诊断准确性研究。
理由:建议对 HIV 感染者 (PWH) 进行基于 C 反应蛋白 (CRP) 的结核病 (TB) 筛查。然而,它在未感染 HIV 的人和不同环境中的表现尚不清楚。目的: 在一项多国研究中,我们旨在确定 CRP 是否满足有效 TB 筛查测试的最低准确性目标 (敏感性 ≥90%,特异性 ≥70%)。方法/测量: 来自非洲和亚洲五个结核病流行国家的连续门诊成人咳嗽 ≥2 周,收集基线血液用于床旁 CRP 检测和 HIV 和糖尿病筛查。收集痰液样本用于 Xpert MTB/RIF Ultra (Xpert) 检测和培养。参考痰液检查结果确定 CRP 敏感性和特异性 (5 mg/L 切点),并按国家、性别、HIV 和糖尿病状况进行比较。使用多变量受试者工作特征 (ROC) 回归模型确定影响 CRP 性能的变量。结果: 在 2904 名参与者中,其中 613 名 (21%) 患有经微生物学证实的结核病,CRP 敏感性为 84% (95% CI: 81-87%) 和特异性为 61% (95% CI: 59-63%)。CRP 准确性因地域而异,非洲国家的敏感性 (≥91%) 高于亚洲国家 (64-82%)。男性的敏感性高于女性 (87% vs. 79%,差异 +8%,95% CI: 1-15%),无 HIV 人群的特异性高于 PWH (64% vs. 45%,差异 +19%,95% CI: 13-25%)。ROC 回归分析确定了国家和结核病严重程度的指标作为 CRP 性能的预测因子。结论: 总体而言,CRP 未达到最低准确率目标,其性能因设置和某些亚组而异,可能反映了分枝杆菌载量的种群差异。
更新日期:2024-12-06
中文翻译:
基于 C 反应蛋白的结核病症状筛查:一项诊断准确性研究。
理由:建议对 HIV 感染者 (PWH) 进行基于 C 反应蛋白 (CRP) 的结核病 (TB) 筛查。然而,它在未感染 HIV 的人和不同环境中的表现尚不清楚。目的: 在一项多国研究中,我们旨在确定 CRP 是否满足有效 TB 筛查测试的最低准确性目标 (敏感性 ≥90%,特异性 ≥70%)。方法/测量: 来自非洲和亚洲五个结核病流行国家的连续门诊成人咳嗽 ≥2 周,收集基线血液用于床旁 CRP 检测和 HIV 和糖尿病筛查。收集痰液样本用于 Xpert MTB/RIF Ultra (Xpert) 检测和培养。参考痰液检查结果确定 CRP 敏感性和特异性 (5 mg/L 切点),并按国家、性别、HIV 和糖尿病状况进行比较。使用多变量受试者工作特征 (ROC) 回归模型确定影响 CRP 性能的变量。结果: 在 2904 名参与者中,其中 613 名 (21%) 患有经微生物学证实的结核病,CRP 敏感性为 84% (95% CI: 81-87%) 和特异性为 61% (95% CI: 59-63%)。CRP 准确性因地域而异,非洲国家的敏感性 (≥91%) 高于亚洲国家 (64-82%)。男性的敏感性高于女性 (87% vs. 79%,差异 +8%,95% CI: 1-15%),无 HIV 人群的特异性高于 PWH (64% vs. 45%,差异 +19%,95% CI: 13-25%)。ROC 回归分析确定了国家和结核病严重程度的指标作为 CRP 性能的预测因子。结论: 总体而言,CRP 未达到最低准确率目标,其性能因设置和某些亚组而异,可能反映了分枝杆菌载量的种群差异。